Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Nov;52(13):3198-3205.
doi: 10.1177/03635465241283052. Epub 2024 Oct 18.

Platelet-Rich Plasma Injections Do Not Improve the Recovery After Arthroscopic Partial Meniscectomy: A Double-Blind Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Platelet-Rich Plasma Injections Do Not Improve the Recovery After Arthroscopic Partial Meniscectomy: A Double-Blind Randomized Controlled Trial

Mirco Lo Presti et al. Am J Sports Med. 2024 Nov.

Abstract

Background: Arthroscopic meniscectomy is one of the most performed surgical procedures in orthopaedics. Different approaches have been proposed to improve patient recovery but with unsatisfactory results. Platelet-rich plasma (PRP) augmentation has been proposed as a strategy to improve the recovery after meniscectomy.

Purpose: To investigate the clinical benefits of an intra-articular PRP injection after meniscectomy, in terms of faster and better patient recovery.

Study design: Randomized controlled trial; Level of evidence, 1.

Methods: Ninety patients were randomized into a treatment group, with arthroscopic partial meniscectomy immediately followed by a 5-mL injection of autologous conditioned plasma, and a control group with partial meniscectomy alone. Patients were evaluated at baseline and at 15, 30, 60, and 180 days of follow-up with the visual analog scale (VAS) score for pain (primary outcome), as well as with International Knee Documentation Committee subjective score, Knee injury and Osteoarthritis Outcome Score subscales, Tegner score, and EuroQol-Visual Analog Scale score. Objective evaluation was performed analyzing knee range of motion and circumference and the International Knee Documentation Committee objective score. Complications, patient judgment, and satisfaction were documented as well.

Results: No major complications and an overall significant improvement in the clinical scores were observed in both groups. Overall, the comparative analysis did not demonstrate significant between-group differences in absolute values or improvements of both subjective and objective scores, as well as activity level. The improvement in terms of VAS pain score for the treatment group was significant already at 15 days (from 4.3 ± 2.5 to 2.5 ± 2.5; P = .014), while in the control group it became significant at 30 days (from 3.7 ± 2.3 to 2.0 ± 2.4; P = .004). No significant differences were observed between the 2 groups in terms of judgment of treatment results and satisfaction.

Conclusion: A single postoperative injection of PRP was not able to significantly improve patient recovery after arthroscopic partial meniscectomy. PRP augmentation did not provide overall benefits at a short-term follow-up (6 months) in terms of pain relief, function, objective parameters, and return-to-sport activities.

Registration: NCT02872753 (ClinicalTrials.gov identifier).

Keywords: PRP; knee; meniscectomy; meniscus; platelet-rich plasma.

PubMed Disclaimer

Conflict of interest statement

One or more of the authors has declared the following potential conflict of interest or source of funding: Arthrex provided kits for this study. S.Z. has received institutional support from Fidia Farmaceutici, Cartiheal, IGEA Clinical Biophysics, Biomet, and Kensey Nash; grant support from I+; and royalties from Springer outside the submitted work. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.

Figures

Figure 1.
Figure 1.
CONSORT (Consolidated Standards of Reporting Trials) flow diagram used in the design of the trial. pts, patients.
Figure 2.
Figure 2.
The visual analog scale for pain trend in the treatment group (left) and control group (right) at baseline and at 15, 30, 60, and 180 days of follow-up. The box-and-whisker plots show the median (whiskers), interquartile range (boxes), and 95% confidence interval (lines). No differences were found between treatment and control groups in terms of absolute values and improvement from baseline.

References

    1. Adams BG, Houston MN, Cameron KL. The epidemiology of meniscus injury. Sports Med Arthrosc Rev. 2021;29(3):e24-e33. - PubMed
    1. Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. - PMC - PubMed
    1. Bahns C, Bolm-Audorff U, Seidler A, Romero Starke K, Ochsmann E. Occupational risk factors for meniscal lesions: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2021;22(1):1042. - PMC - PubMed
    1. Beaufils P, Pujol N. Management of traumatic meniscal tear and degenerative meniscal lesions. Save the meniscus. Orthop Traumatol Surg Res. 2017;103(8S):S237-S244. - PubMed
    1. Belk JW, Keeling LE, Kraeutler MJ, et al.. Risk of infection in knee arthroscopy patients undergoing corticosteroid injections in the perioperative period. Orthop J Sports Med. 2021;9(8):23259671211032941. - PMC - PubMed

Publication types

Associated data